Send the following on WhatsApp
Continue to ChatTocilizumab, RoActemra*, et risque de perforation intestinale https://www.pharmacorama.com/2016/12/tocilizumab-roactemra-risque-perforation-intestinale/
Tocilizumab, RoActemra*, et risque de perforation intestinale https://www.pharmacorama.com/2016/12/tocilizumab-roactemra-risque-perforation-intestinale/